May God Bless and Protect our Troops.
Please always remember “Freedom is NOT Free”
With “Thanks, Gratitude & Respect”
Posted in Uncategorized | Tagged Memorial Day 2018 | Leave a Comment »
|
Download the full report.
Background
This report analyzes the terms of 200 venture financings closed in the first quarter of 2018 by companies headquartered in Silicon Valley.
Overview of Results
Valuation Results Remain Strong but Have Flattened
Valuation results were generally flat in Q1 2018 compared to the prior quarter. Overall, valuation metrics are well above historical averages, but have plateaued since Q3 2017. Up rounds exceeded down rounds 75% to 15%, with 10% flat in Q1 2018, an increase from Q4 2017 when up rounds exceeded down rounds 70% to 19%, with 11% flat.
The Fenwick & West Venture Capital Barometer™ showed an average price increase in Q1 2018 of 74%, which was flat compared to the prior quarter. The average price increase had previously peaked in Q3 2017 after five consecutive quarters of increases before decreasing moderately in Q4 2017.
The median price increase of financings in Q1 2018 was 41%, a slight decrease from the 42% recorded in Q4 2017, and the second consecutive quarter of declines following four quarters of increases.
Internet/Digital Media Continues to Score Highest Valuation Results
Similar to the prior quarter, the internet/digital media industry recorded the strongest valuation results in Q1 2018 compared to the other industries, with an average price increase of 101% and a median price increase of 59%. However, the valuation results for the internet/digital media industry were moderately weaker compared to the prior quarter.
In contrast, the software, hardware and life sciences industries all recorded stronger valuation results in Q1 compared to the prior quarter. The hardware industry, in particular, recorded the second strongest valuation results in Q1 and the greatest improvement in valuation results compared to the prior quarter, with the average price increase increasing from 40% in Q4 2017 to 97% in Q1 2018 and the median price increase increasing from 13% in Q4 2017 to 52% in Q1 2018.
Download the full report covering top line trends for venture capital financings of Silicon Valley companies in Q1.
Posted in Uncategorized | Tagged Catherine Clarfield Hess, Fenwick & West, Khang Tran, Mark A Leahy, Silicon Valley VC Survey | Leave a Comment »
Good Afternoon
The objective of this email is to qualify any interest on your company may have in utilizing the services of Gerbsman Partners to help maximize and monetize value of Intellectual Property which the company would like to sell or license to others.
Gerbsman Partners has observed that some medical device and life science companies have developed or acquired through acquisition Intellectual Property, that are not being fully utilized and can generate considerable value.
Given such situations, the Gerbsman Partners team is available to discuss and develop plans and strategies that can lead to the goal of monetizing and maximizing value of this IP.
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property, as well as maximizing value for Intellectual Property Patents & Processes. Since 2001, Gerbsman Partners has been involved in maximizing value for 103 technology, medical device, life science, solar, fuel cell, cyber security, consumer and digital marketing companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A Transactions.
Gerbsman Partners has offices and strategic alliances in San Francisco, New York, McLean, VA/Washington DC, Orange County, Boston, Europe and Israel.
I look forward to speaking with you.
Best regards
Steve Gerbsman
Medial Device
Cardiovascular, Vascular, Endoscopy, Breast Imaging
- Cardiomind Inc. – Stent delivery platform.
- OmniSonics Medical Technologies Inc. – Vascular disease IP.
- InnerPulse Inc. – Cardiac rhythm management (CRM) medical device company.
- Myocor Inc. – Developing innovative cardiac reshaping devices to treat functional mitral regurgitation (FMR) and left ventricular (LV) dysfunction, both of which are significant in the progression of congestive heart failure (CHF).
- NDO Surgical, Inc. – Flexible endoscopy technologies that enable surgical procedures through the body’s natural openings.
- Viacor Inc. – Cardiac implant device for the treatment of functional mitral regurgitation.
- XTENT Inc. – Customizable drug eluting stent systems for the treatment of cardiovascular disease.
- GluMetrics, Inc. – Glucose monitoring medical device company
- NeoGraft Technologies, Inc. – Acquired Vascular Patents from Kips Bay Medical
- Palmaz Scientific, Inc. – Medical technology company
- InterValve, Inc. – Medical devices for structural heart market
- Gamma Medica – first fully digital, dual headed Molecular Breast Imaging (“MBI”) system
Spine
- Applied Spine Technologies Inc. – Screw based dynamic stabilization system validated with Class 1 clinical data
- AxioMed Spine, Corp. – Developed Freedom technology, with the goal of restoring spinal function to patients by adhering to the natural biomechanics of the spine.
Respiratory
- Emphasis Medical Inc. – Endobronchial valves for the treatment of heterogeneous emphysema.
- Uptake Medical, Inc. – developing innovative, therapeutic bronchoscopic devices to treat advanced heterogeneous emphysema and lung cancer.
Orthopedics
- NovaLign Orthopedic Inc. – Long bone fracture, intramedullary nail technology.
Opthomology
- Optobionics – Retinal degeneration.
- Refractec, Inc. – Radiofrequency (RF) device called ViewPoint CK System, used to perform NearVisionSM CK (Conductive Keratoplasty) treatment
Obesity
- Satiety Inc. – Obesity product
Osteoperosis
• Tarsa Therapeutics – Oral formulation contains recombinant salmon calcitonin – treatment pf postmenopausal osteoporosis
Life Science
- Pluristem, Inc. – Stem cell research – Israel company
- Igenica Biotherapeutics, Inc.. – harnessing the natural tumor microenvironment to deliver a pipeline of high-impact antibody-based cancer therapeutics
- Pegasus Biologics Inc. – Developed and is commercializing a revolutionary bioscaffold comprised of highly organized collagen, sourced from equine pericardium that encourages the healing process by addressing the demands of a challenging biological environment.
- Radiant Medical, Inc. – Endovascular therapeutic cooling.
- Valentis, Inc. – Biotechnology company with small molecule, antibody, protein, gene and manufacturing assets.
- Relypsa, Inc. – Acquisition of BioPharmaceutical Patents and Intellectual Property
Posted in Uncategorized | Tagged Gerbsman Partners, Life science, Medical Device | Leave a Comment »
The Funded: 5 Bay Area startups raise over $100M, Google buys one from Santa Clara
Santa Clara-based 3D printing startup Arevo has created a bike with its technology and raised a Series B round of funding.
By Cromwell Schubarth TechFlash Editor, Silicon Valley Business Journal
Five Bay Area startups disclosed more than $100 million in funding at week’s end and Google bought another one.
Here are the details.
• Parsable Inc., San Francisco, $40 million: Future Fund led the Series C round for this provider of a digital workflow platform for deskless industrial workers. It was joined by B37 and return backers Lightspeed Venture Partners, Airbus Ventures and Aramco Ventures.
• DigiLens Inc., Sunnyvale, $25 million: Continental AG invested in the Series C round of this augmented reality display maker for autos, planes and other devices. Read more here.
• Mynd Property Management, Oakland, $20 million: Lightspeed Venture Partners led the Series B round for this property management tech startup. It was joined by return backers Canaan Partners and Jackson Square Ventures.
• Arevo, Santa Clara, $12.5 million: Asahi Glass led the Series B round for this creator of a 3D printed carbon bike. It was joined by Sumitomo, Leslie Ventures and Khosla Ventures.
• BlueCart Inc., Mountain View, $5 million: Greycroft led the Series B1 investment in this hospitality industry marketplace and sales enablement platform provider.
M&A
• Cask Data Inc., Palo Alto, undisclosed amount: Google acquired this Big Data analytics startup that had raised around $40 million from firms that included Insight Venture Partners, Ericsson Ventures, Battery Ventures, AME Cloud Ventures and Ignition Partners.
Posted in Uncategorized | Tagged Bay Area Startups, Cromwell Schubarth, Silicon Valley Business Journal | Leave a Comment »
IBM To Use Stellar For Its First Crypto-Token On A Public Blockchain
, I cover enterprise adoption of blockchain and cryptocurrency.
(Photo by Joan Cros Garcia/Corbis via Getty Images)
The International Business Machines Corporation is issuing its first token using a public blockchain
Developed in partnership with carbon credits startup Veridium Labs Ltd., the “verde” tokens will be issued on the Stellar blockchain, and are designed to give enterprises that pollute the environment a way to offset that damage by supporting a patch of Indonesian rainforest.
While carbon credits in their own right are not new, the process of tracking the full extent of one’s pollution, then providing assurance that the money was actually used to replenish the environment is both time-consuming and opaque.
By moving this process to an easily auditable blockchain, and tokenizing the credits in a similar way that a bitcoin tokenizes monetary value, IBM’s newly appointed blockchain offering manager, Jared Klee, believes a vibrant market could eventually be opened up to a much larger audience.
“We’re creating a fungible digital asset, a token which part of the goal is to create a market where people can buy, sell, trade and then redeem it for the underlying credits,” said Klee, who was put in charge of IBM’s token initiatives earlier this year. “By having a liquid market you open up a world of possibilities.”
The verde carbon credit tokens, are built on top of the public Stellar blockchain and via a series of smart contracts follow the entire process of accounting for a company’s carbon emission and offsetting that pollution.
“Our engagement with Veridium will mark the first public IBM involvement in a token issuance on a public network,” said Klee. But in a twist that is finding increasing favor among blockchain developers, there is also a permissioned component via IBM’s own blockchain technology.
Klee says this “public, permissoined” model is what allows IBM and Veridium to create a market for the buying and selling of the tokenized carbon credits that will also be restricted to participants in accordance with regulatory requirements. To facilitate that permissioning while still capitalizing on Stellar’s public blockchain, IBM manages nine nodes on the Stellar blockchain.
“Not only does that help create stability for the Stellar network,” said Klee. “But that allows us to work with Veridium as the issuer and create a point of review in the transaction flow before it gets committed to the ledger.” But going forward that could be further opened up, with Klee adding that he too would like to someday be able to personally offset his own carbon footprint using the exchange.
More than just a proof-of-concept, the Veridium tokens will be backed by Triple Gold REDD+ credits from Veridium’s sister company InfiniteEarth, founded in 2008 to help companies offset their environmental impact in a number of ways. While Veridium hasn’t revealed the names of its own potential customers, InfiniteEarth counts Big Four accounting firm PwC, and software giants, SAP and Microsoft among its customers, all of which has their own ongoing blockchain projects, making them possibly suitable adopters.
Posted in Uncategorized | Tagged Crypto-Token, Forbes, IBM, Michael del Castillo | Leave a Comment »
Blog of Intellectual Capital 